COE Projects: |
Funding Agencies |
Title |
Project Cost (in Lakhs) |
Duration |
| CCRAS, Ministry of Ayush |
Evaluation of the anti-pyretic and anti-asthmatic activity of the Ayurvedic formulations Ayush GBP and Ayush CPP in experimental models. Principal Investigator, F. No. HQ-PROJ011/120/2024-PROJ, Office Order: 1349/2024-25, Dated: 11.03.2025 |
20.07 Lakhs |
6 months |
| ICMR, Govt. of India |
Encapsulation of tubulin binding agent, Noscapinoids with PEG-PLGA-FA di-block to enhance circulation time, sustain release and delivery to breast tumor cells by targeting folate receptor. Principal Investigator, Sanction Id: EMDR/SG/15/2024-01-03232, Dated: 09.01.2025 |
53.66 Lakhs |
3 years |
| NABARD |
Innovation in commercial level production of Agri-Horticulture crops and imparting capacity building of FPOs/Farmers/SHGs towards livelihood opportunities in Sambalpur district, Odisha. Principal Investigator, Sanction ID: NB.ODI/FSDD/122167/FSPF-DPR/2024-25, Dated: 09.01.2025 |
37.09 Lakhs |
2 years |
| SPCB, Govt. of Odisha |
Enumeration of heavy metals and pesticide residues in water, soil, rice grains, crop vegetables and patient samples and their impact on public health in and around the Hirakud irrigated command areas, Sambalpur, Odisha, Principal Investigator, Sanction No. 692/SPCB/ICZM/603/23-24, Dated: 28.12.2023 |
48.00 Lakhs |
2 years |
| CCRAS, Ministry of Ayush |
Aqueous and hydroalcoholic extraction of selected anukta dravya plants and evaluation of their therapeutic efficacy for various diseases, Principal Investigator, Sanction No. 1258/2022-23, Dated: 16.02.2023 |
115.84 Lakhs |
2 years |
| CCRAS, Ministry of Ayush |
Mechanistic studies in elucidation of shodhana for nine poisonous medicinal plants of E1 schedule, Principal Investigator, Sanction No. 1458/2022-23, Dated: 22.03.2023 |
25.24 Lakhs |
3 years |
| DBT, Govt. of India |
DBT-Boost to University Interdisciplinary Life Science Departments for Education and Research (DBT-BUILDER) |
534.00 |
5.0 Years |
| ICMR Govt. of India |
Optimization of natural anticancer agent, Noscapine by rational design of its derivatives: chemical synthesis and preclinical evaluation for the management of breast cancer. |
48.41 |
3.0 Years |
| ICMR Govt. of India |
Targeting specifically breast tumor cells by developing potent derivative of tubulin binding anticancer agent, noscapine and conjugating it with folic acid. |
51.00 |
3.0 Years |
| DST-SERB, Govt. of India |
Isolation and characterisation of novel anticancer and immunomodulatory compounds from a medicinal herb Remusatia vivipara Schott. Found in Gandhamardan hills, Western Odisha |
30.69 |
3.0 Years |
| DBT, Govt. of India |
Development of synthetic derivatives of natural compound, Noscapine as tubulin binding chemotherapeutic agent and evaluation of its synergistic effect with Taxotere for management of human breast cancer |
24.00 |
3.0 Years |
| ICMR, Govt. of India |
Big data platform for temporal storage of clinical data of patients of cardiovascular diseases and data mining for better diagnosis and treatment |
21.15 |
3.0 Years |
| DBT, Govt. of India |
Development of value added food products from Mahua and Moringa, Entrepreneurship Development Programme in Biotechnology |
94.50 |
3.0 Years |
| ICMR, Govt. of India |
Elucidation of the distribution pattern of human pancreatic islets (α- and β- cells) and association mapping with myosin-Va motor protein. |
17.42 |
3.0 Years |
| DST, Govt. of India |
Funds for Improvement of Science & Technology Infrastructure (DST-FIST, Phase I) |
68.00 |
5.0 Years |
| DST, Govt. of Odisha |
Preclinical efficacy evaluation of extremely promising novel noscapinoid: A tubulin-binding agent in the management of breast cancer |
8.96 |
3.0 Years |
| CCRAS-1, Ministry of Ayush |
Aqueous and hydro alcoholic extraction of selected anukta dravya plants and evaluation of their therapeutic efficacy of various disease |
116.068 |
3.0 Years |
| CCRAS-2, Ministry of Ayush |
Mechanistic studies in elucidation of shodhana for nine poisonous medicinal plants of E1 schedule |
25.25 |
3.0 Years |
